BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,434,286 | -2.8% | 223,484 | +17.3% | 0.13% | +0.8% |
Q2 2023 | $8,676,811 | +129.7% | 190,448 | +104.5% | 0.13% | +120.7% |
Q1 2023 | $3,777,677 | -12.6% | 93,138 | +9.8% | 0.06% | -17.1% |
Q4 2022 | $4,322,562 | -10.5% | 84,806 | -5.4% | 0.07% | -17.6% |
Q3 2022 | $4,830,000 | -15.5% | 89,674 | +0.8% | 0.08% | -11.5% |
Q2 2022 | $5,713,000 | -7.7% | 88,943 | +11.4% | 0.10% | +9.1% |
Q1 2022 | $6,191,000 | -3.4% | 79,844 | +6.9% | 0.09% | +3.5% |
Q4 2021 | $6,409,000 | -8.1% | 74,662 | -13.9% | 0.08% | -14.1% |
Q3 2021 | $6,973,000 | +7.0% | 86,696 | +7.1% | 0.10% | +6.5% |
Q2 2021 | $6,514,000 | +1.7% | 80,927 | +6.6% | 0.09% | -6.1% |
Q1 2021 | $6,405,000 | +42.3% | 75,949 | +35.4% | 0.10% | +32.0% |
Q4 2020 | $4,500,000 | +2.5% | 56,085 | +2.7% | 0.08% | -11.8% |
Q3 2020 | $4,392,000 | +44.5% | 54,608 | +54.6% | 0.08% | +34.9% |
Q2 2020 | $3,039,000 | +18.0% | 35,311 | +11.3% | 0.06% | 0.0% |
Q1 2020 | $2,575,000 | -3.6% | 31,718 | -0.7% | 0.06% | +12.5% |
Q4 2019 | $2,671,000 | -0.7% | 31,944 | +3.8% | 0.06% | -6.7% |
Q3 2019 | $2,691,000 | +10.4% | 30,761 | +3.4% | 0.06% | +11.1% |
Q2 2019 | $2,437,000 | +19.6% | 29,759 | +18.8% | 0.05% | +17.4% |
Q1 2019 | $2,037,000 | +21.0% | 25,044 | -2.1% | 0.05% | +9.5% |
Q4 2018 | $1,683,000 | -17.7% | 25,576 | -3.6% | 0.04% | -6.7% |
Q3 2018 | $2,045,000 | +19.9% | 26,533 | +14.8% | 0.04% | +7.1% |
Q2 2018 | $1,706,000 | +23.3% | 23,109 | +8.6% | 0.04% | +20.0% |
Q1 2018 | $1,384,000 | -1.4% | 21,278 | -4.8% | 0.04% | -5.4% |
Q4 2017 | $1,403,000 | 0.0% | 22,362 | 0.0% | 0.04% | +2.8% |
Q3 2017 | $1,403,000 | +0.9% | 22,362 | -2.6% | 0.04% | -5.3% |
Q2 2017 | $1,390,000 | +21.5% | 22,966 | +4.1% | 0.04% | +15.2% |
Q1 2017 | $1,144,000 | – | 22,065 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |